Invitro Maturation of Oocytes for Patients With Polycystic Ovaries

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by Assaf-Harofeh Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Assaf-Harofeh Medical Center
ClinicalTrials.gov Identifier:
NCT00631982
First received: March 3, 2008
Last updated: March 7, 2008
Last verified: March 2008
  Purpose

In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.


Condition Intervention
Infertility
Polycystic Ovaries
Procedure: in vitro matuartion of oocytes

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: In Vitro Maturation of Oocytes for Patients With Polycystic Ovaries

Resource links provided by NLM:


Further study details as provided by Assaf-Harofeh Medical Center:

Primary Outcome Measures:
  • maturation rate, [ Time Frame: 18 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Fertilization rate, pregnancy rate [ Time Frame: 18 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 30
Study Start Date: April 2008
Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Group I
patients with PCO undergoing in vitro maturation and subsequently IVF and embryo transfer
Procedure: in vitro matuartion of oocytes
in vitro maturation of (immature) oocytes

  Eligibility

Ages Eligible for Study:   18 Years to 39 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Polycystic ovaries
  • Needing IVF for fertility treatment

Exclusion Criteria:

  • Age above 39
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00631982

Contacts
Contact: Raphael Ron - El, MD +972-8-9779005

Locations
Israel
IVF and Infertility Unit, Assaf Harofeh Medical Center Not yet recruiting
Zerifin, Israel, 70300
Contact: Raphael Ron-El, MD    +972-8-9779005      
Principal Investigator: Raphael Ron - El, MD         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
  More Information

No publications provided

Responsible Party: IVF and Infertility Unit, Assaf Harofeh Medical Center, Zerifin Israel, Assaf Harofeh Medical Center, Zerifin Israel
ClinicalTrials.gov Identifier: NCT00631982     History of Changes
Other Study ID Numbers: 22/08
Study First Received: March 3, 2008
Last Updated: March 7, 2008
Health Authority: Israel: Ministry of Health

Keywords provided by Assaf-Harofeh Medical Center:
in vitro maturation oocytes

Additional relevant MeSH terms:
Infertility
Polycystic Ovary Syndrome
Genital Diseases, Male
Genital Diseases, Female
Ovarian Cysts
Cysts
Neoplasms
Ovarian Diseases
Adnexal Diseases
Gonadal Disorders
Endocrine System Diseases

ClinicalTrials.gov processed this record on October 16, 2014